220 related articles for article (PubMed ID: 32202774)
21. Systematic Analysis of Chemical Modifications of Phosphorothioate Antisense Oligonucleotides that Modulate Their Innate Immune Response.
Pollak AJ; Zhao L; Crooke ST
Nucleic Acid Ther; 2023 Apr; 33(2):95-107. PubMed ID: 36749166
[TBL] [Abstract][Full Text] [Related]
22. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
Wang Y; Shen W; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
[TBL] [Abstract][Full Text] [Related]
23. Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective.
Liang XH; De Hoyos CL; Shen W; Zhang L; Fazio M; Crooke ST
Nucleic Acid Ther; 2021 Apr; 31(2):126-144. PubMed ID: 33534636
[TBL] [Abstract][Full Text] [Related]
24. Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.
Miller CM; Wan WB; Seth PP; Harris EN
Nucleic Acid Ther; 2018 Apr; 28(2):86-96. PubMed ID: 29437530
[TBL] [Abstract][Full Text] [Related]
25. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
Vickers TA; Rahdar M; Prakash TP; Crooke ST
Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
[TBL] [Abstract][Full Text] [Related]
26. Integrated Assessment of the Clinical Performance of GalNAc
Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS
Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431
[TBL] [Abstract][Full Text] [Related]
27. The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents.
Crooke ST; Seth PP; Vickers TA; Liang XH
J Am Chem Soc; 2020 Sep; 142(35):14754-14771. PubMed ID: 32786803
[TBL] [Abstract][Full Text] [Related]
28. Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs.
Liang XH; Nichols JG; De Hoyos CL; Sun H; Zhang L; Crooke ST
Nucleic Acids Res; 2021 Aug; 49(14):8277-8293. PubMed ID: 34244781
[TBL] [Abstract][Full Text] [Related]
29. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.
Liang XH; Shen W; Sun H; Prakash TP; Crooke ST
Nucleic Acids Res; 2014 Jul; 42(12):7819-32. PubMed ID: 24861627
[TBL] [Abstract][Full Text] [Related]
30. Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging.
Mukherjee P; Aksamitiene E; Alex A; Shi J; Bera K; Zhang C; Spillman DR; Marjanovic M; Fazio M; Seth PP; Frazier K; Hood SR; Boppart SA
Nucleic Acid Ther; 2022 Jun; 32(3):163-176. PubMed ID: 34797690
[TBL] [Abstract][Full Text] [Related]
31. Antisense oligonucleotides and nucleic acids generate hypersensitive platelets.
Zaslavsky A; Adams M; Cao X; Yamaguchi A; Henderson J; Busch-Østergren P; Udager A; Pitchiaya S; Tourdot B; Kasputis T; Church SJ; Lee SK; Ohl S; Patel S; Morgan TM; Alva A; Wakefield TW; Reichert Z; Holinstat M; Palapattu GS
Thromb Res; 2021 Apr; 200():64-71. PubMed ID: 33540294
[TBL] [Abstract][Full Text] [Related]
32. Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.
Schmidt K; Prakash TP; Donner AJ; Kinberger GA; Gaus HJ; Low A; Østergaard ME; Bell M; Swayze EE; Seth PP
Nucleic Acids Res; 2017 Mar; 45(5):2294-2306. PubMed ID: 28158620
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.
Liang XH; Sun H; Shen W; Crooke ST
Nucleic Acids Res; 2015 Mar; 43(5):2927-45. PubMed ID: 25712094
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.
Wan WB; Migawa MT; Vasquez G; Murray HM; Nichols JG; Gaus H; Berdeja A; Lee S; Hart CE; Lima WF; Swayze EE; Seth PP
Nucleic Acids Res; 2014 Dec; 42(22):13456-68. PubMed ID: 25398895
[TBL] [Abstract][Full Text] [Related]
35. Insights into innate immune activation via PS-ASO-protein-TLR9 interactions.
Pollak AJ; Zhao L; Vickers TA; Huggins IJ; Liang XH; Crooke ST
Nucleic Acids Res; 2022 Aug; 50(14):8107-8126. PubMed ID: 35848907
[TBL] [Abstract][Full Text] [Related]
36. Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines.
Linnane E; Davey P; Zhang P; Puri S; Edbrooke M; Chiarparin E; Revenko AS; Macleod AR; Norman JC; Ross SJ
Nucleic Acids Res; 2019 May; 47(9):4375-4392. PubMed ID: 30927008
[TBL] [Abstract][Full Text] [Related]
37. Structural dynamics of therapeutic nucleic acids with phosphorothioate backbone modifications.
Carlesso A; Hörberg J; Deganutti G; Reymer A; Matsson P
NAR Genom Bioinform; 2024 Jun; 6(2):lqae058. PubMed ID: 38800826
[TBL] [Abstract][Full Text] [Related]
38. Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides.
Genna V; Iglesias-Fernández J; Reyes-Fraile L; Villegas N; Guckian K; Seth P; Wan B; Cabrero C; Terrazas M; Brun-Heath I; González C; Sciabola S; Villalobos A; Orozco M
Nucleic Acids Res; 2023 Jun; 51(10):4713-4725. PubMed ID: 37099382
[TBL] [Abstract][Full Text] [Related]
39. Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry.
Terada C; Oh K; Tsubaki R; Chan B; Aibara N; Ohyama K; Shibata MA; Wada T; Harada-Shiba M; Yamayoshi A; Yamamoto T
Nat Commun; 2023 Dec; 14(1):7972. PubMed ID: 38042877
[TBL] [Abstract][Full Text] [Related]
40. Hsc70 Facilitates Mannose-6-Phosphate Receptor-Mediated Intracellular Trafficking and Enhances Endosomal Release of Phosphorothioate-Modified Antisense Oligonucleotides.
Liang XH; Nichols JG; Hsu CW; Crooke ST
Nucleic Acid Ther; 2021 Aug; 31(4):284-297. PubMed ID: 33567234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
